Proteomic profiling of VCP substrates links VCP to K6‐linked ubiquitylation and c‐Myc function

Abstract

Valosin‐containing protein (VCP) is an evolutionarily conserved ubiquitin‐dependent ATPase that mediates the degradation of proteins through the ubiquitin–proteasome pathway. Despite the central role of VCP in the regulation of protein homeostasis, identity and nature of its cellular substrates remain poorly defined. Here, we combined chemical inhibition of VCP and quantitative ubiquitin remnant profiling to assess the effect of VCP inhibition on the ubiquitin‐modified proteome and to probe the substrate spectrum of VCP in human cells. We demonstrate that inhibition of VCP perturbs cellular ubiquitylation and increases ubiquitylation of a different subset of proteins compared to proteasome inhibition. VCP inhibition globally upregulates K6‐linked ubiquitylation that is dependent on the HECT‐type ubiquitin E3 ligase HUWE1. We report ~450 putative VCP substrates, many of which function in nuclear processes, including gene expression, DNA repair and cell cycle. Moreover, we identify that VCP regulates the level and activity of the transcription factor c‐Myc. ![][1] Mass spectrometry‐based proteomics identifies putative substrates of the ubiquitin‐dependent remodeler VCP in human cells and reveals its role in the regulation of the c‐Myc level and activity. Chemical inhibition of VCP increases cellular K6‐linked ubiquitylation that is dependent on the HECT‐type ubiquitin ligase HUWE1. EMBO Reports (2018) e44754 [1]: /embed/graphic-1.gif